“I hope we find a cure and I’m out of a job some day soon and I can work on something else,” says Zandrea Ambrose, Associate Professor of Medicine and HIV researcher at the University of Pittsburgh School of Medicine.
Dr. Ambrose is passionate about ending the harmful impacts of HIV around the world. On the occasion of World AIDS Day 2017, we checked in with her to learn a bit about her work as a virologist and her hopes for the future of HIV treatment and research.
“We’ve seen such great success with Pre-Exposure Prophylaxis (PrEP), and I’m glad that the work we’ve done at the University of Pittsburgh has contributed to the understanding of effective prevention and treatments,” says Ambrose. “We are still working toward making treatments easier to use and access. It motivates my work every day. Patients sometimes have difficulty adhering to their medication schedule, and we’re working on other treatment options,” says Ambrose. There is very promising evidence that a sustained release shot of antiretroviral drugs, given monthly or every other month, may soon be available to keep HIV viral loads suppressed and at an undetectable level.
In addition to her work as a researcher and educator, Dr. Ambrose has served on the Board of Directors at PERSAD Center since 2009. “PERSAD has played an important and sustained role in helping people with HIV since the 1980s, and I’m glad to serve an organization that is helping the LGBTQ communities in so many important ways,” says Ambrose. At PERSAD, we are glad to have Dr. Ambrose helping us achieve our mission.